Top 5 Life Science Angel Investors in Belgium
A list of 5 angel investors that invest in Life science startups based in Belgium. We rank investors based on the number of investments they made in Life science companies from Belgium. We update this investor list every month.Top 5 Life Science Angel Investors in Belgium
Investor | Life Science Belgium investments |
---|---|
Luc Vauterin | 2 |
Annie Vereecken | 2 |
Pierre Drion | 2 |
Kenneth Buckfire | 1 |
Evren Ucok | 1 |
Luc Vauterin - Board Member @ ONTOFORCE
Show more
Investment focus
- Life Science, Data Integration, Data Visualization
- Seed, Series A
- Belgium
Portfolio highlights
- ONTOFORCE — ONTOFORCE creates and implements pioneering semantic search technology for information management. Our user-friendly data search platform DISQOVER builds uniquely intelligent links between heterogeneous data sources, allowing everybody to become a data scientist.
Annie Vereecken
Show more
Investment focus
- Biotechnology, Medical, Hospital
- Seed, Series A, Funding Round
- Belgium
Portfolio highlights
- Ziphius — Ziphius Vaccines is a biopharmaceutical company dedicated to developing next-generation vaccines for the prevention of infectious diseases.
- Sensolus — Introducing our smart, industrial-grade tracking solution. With battery life of up to ten years, and no additional infrastructure needed.
- Allegro Biotech — Allegro has developed the world’s-first custom-tailored, durable, biocompatible, anisotropic, regenerative meniscus cartilage, providing immediate support while also leverage the body’s own healing potential to regenerate human cartilage (proliferation and differentiation of fibrochondrocyte cells).
Pierre Drion - CEO @ Petercam
Show more
Investment focus
- Biotechnology, Health Care, Life Science
- Series A, Series B, Funding Round
- Belgium
Portfolio highlights
- A-Mansia Biotech — A-Mansia Biotech is a developer of products based on the properties of the Akkermansia muciniphila (A. muciniphila) bacterium. The company's nutritional supplement based on a gut bacterium called Akkermansia, the population of microorganisms housed in the gastrointestinal tract. A. muciniphila is located in the mucus layer covering theintestinal epithelium, which allows the bacterium to establish a close cross-talk with the host.
- Novadip Biosciences — Novadip Biosciences, an advanced biopharmaceutical company focused on new generation of therapies from adipose stem cells adapted to hard and soft tissues reconstruction.
- Santero Therapeutics — Santero Therapeutics seeks to provide novel medications with fresh modes of action that combat diseases with high resistance. Santero develops antimicrobials with novel modes of action to combat the rise of antibiotic-resistant microorganisms.
Kenneth Buckfire is the Chief Executive Officer at Miller Buckfire.
Show more
Investment focus
- Medical, Health Care, Life Science
- Series A
- Belgium
Portfolio highlights
- Amyl Therapeutics — Amyl Therapeutics is a preclinical stage biotechnology company. Amyl Therapeutics uses a novel mechanism to bind to the amyloid fold of toxic protein aggregates of various types, including antibody light chain (AL) or transthyretin (TTR) aggregates, which accumulate in peripheral organs to cause systemic amyloidosis diseases, but also amyloid-β(Aβ), Tau, and α-synuclein aggregates, which accumulate in the brain to cause Alzheimer's and Parkinson's diseases.
Evren Ucok is a co-founder and investor at Peak Games, an interactive social game development platform.
He is also a partner at Earlybird Venture Capital, an investment fund-based in Europe that focuses on emerging companies; Trendyol.com, a fashion e-commerce site; and Oliver Wyman.
Show more
Investment focus
- Medical, Health Care, Life Science
- Series A
- Turkey, Belgium
Portfolio highlights
- idemama — Idemama is an online platform that provides its users with web and graphic design services. It is based in Istanbul, Turkey.
- Amyl Therapeutics — Amyl Therapeutics is a preclinical stage biotechnology company. Amyl Therapeutics uses a novel mechanism to bind to the amyloid fold of toxic protein aggregates of various types, including antibody light chain (AL) or transthyretin (TTR) aggregates, which accumulate in peripheral organs to cause systemic amyloidosis diseases, but also amyloid-β(Aβ), Tau, and α-synuclein aggregates, which accumulate in the brain to cause Alzheimer's and Parkinson's diseases.
Investors by industry
Climate
Community
Gaming
Energy
FinTech
Impact
Biotech
Media (entertainment)
Hardware
Proptech
Marketplace
Artificial intelligence
Consumer
Health Care
EdTech
Sustainability
Agriculture (agtech)
Venture Capital
Photography
B2B
Infrastructure
Education
Food and Beverage
Payments
Video Games
Retail
Fashion
Finance
Publishing
Clean Energy
Financial Services
Big Data
Web3
Beauty
Oil and Gas
Real Estate
Organic Food
Medical
Social Network
Wellness
Travel
Android
Recruiting
Cannabis
Biotechnology
Fitness
Social Media
Platforms
Digital Media
Hospitality
Google
Mobile Advertising
Mobile
Franchise
Medical Device
Music
Sports
Automotive
Wine And Spirits
Facebook
Crowdfunding
Legal
Social
eSports
Local
CleanTech
Construction
Email
Transportation
Enterprise Software
Mobile Apps
Internet
Art
InsurTech
Manufacturing
Enterprise
LGBT
Theatre
Film
Life Science
Non Profit
SaaS
Renewable Energy
Sporting Goods
Restaurants
Celebrity
Software
Social Impact
Blockchain
Cryptocurrency
Investors by country
South Korea
New Zealand
Germany
Ireland
United States
Australia
India
United Kingdom
Canada
Japan
Vietnam
Sri Lanka
China
Saudi Arabia
Middle East
Africa
Oceania
Asia
Europe
Indonesia
Singapore
Spain
Armenia
LATAM
Brazil
Qatar
South Africa
Georgia
Bahrain
Belize
Ethiopia
Bermuda
Chile
Costa Rica
France
Estonia
Ghana
Denmark
Belarus
Czech Republic
Ecuador
Egypt
Croatia
Finland
Hong Kong
Algeria
Gibraltar
Faroe Islands
Greece
Hungary
Barbados
Belgium
Bulgaria
Kenya
Mexico
Morocco
Portugal
Kazakhstan
Thailand
Panama
Slovenia
Serbia
Kuwait
Sierra Leone
Rwanda
Cayman Islands
Poland
San Marino
Zimbabwe
Turkey
Liberia
Seychelles
Malta
Jersey
Liechtenstein
Tanzania
Sweden
Norway
Puerto Rico
Taiwan
Peru
Uruguay
Senegal
Israel
Venezuela
El Salvador
Malaysia
Zambia
Tunisia
Uzbekistan
Mauritius
Uganda
Russian Federation
Lithuania
Togo
Ukraine
Mali
Tajikistan
Philippines
Dominican Republic
Nicaragua
Azerbaijan
Bahamas
Cambodia
Lebanon
Nigeria
Myanmar
Italy
Namibia
Iraq
Iceland
United Arab Emirates
Bolivia
Honduras
Isle of Man
Luxembourg
Pakistan
Albania
Oman
Bangladesh
Argentina
Romania
Jordan
Grenada
Cyprus
Latvia
Austria
Switzerland
Cameroon
Guatemala
Colombia
Marshall Islands
Angel Investors in Belgium by industry
Biotechnology
Marketplace
Food and Beverage
Financial Services
Big Data
Finance
Media (entertainment)
Life Science
Medical
Medical Device
Internet
Social Media
Manufacturing
Mobile
Software
Sports
Enterprise Software
Hospitality
Automotive
FinTech
Enterprise
Health Care
Biotech
Climate
Proptech
SaaS
Community
Gaming
Real Estate
Transportation
Publishing
Retail
Payments
Platforms
Artificial intelligence
Hardware
Construction